305 related articles for article (PubMed ID: 34086398)
1. Mechanisms of angiogenic incompetence in Hutchinson-Gilford progeria via downregulation of endothelial NOS.
Gete YG; Koblan LW; Mao X; Trappio M; Mahadik B; Fisher JP; Liu DR; Cao K
Aging Cell; 2021 Jul; 20(7):e13388. PubMed ID: 34086398
[TBL] [Abstract][Full Text] [Related]
2. Identification of mitochondrial dysfunction in Hutchinson-Gilford progeria syndrome through use of stable isotope labeling with amino acids in cell culture.
Rivera-Torres J; Acín-Perez R; Cabezas-Sánchez P; Osorio FG; Gonzalez-Gómez C; Megias D; Cámara C; López-Otín C; Enríquez JA; Luque-García JL; Andrés V
J Proteomics; 2013 Oct; 91():466-77. PubMed ID: 23969228
[TBL] [Abstract][Full Text] [Related]
3. Dysfunction of iPSC-derived endothelial cells in human Hutchinson-Gilford progeria syndrome.
Matrone G; Thandavarayan RA; Walther BK; Meng S; Mojiri A; Cooke JP
Cell Cycle; 2019 Oct; 18(19):2495-2508. PubMed ID: 31411525
[TBL] [Abstract][Full Text] [Related]
4. In vivo base editing rescues Hutchinson-Gilford progeria syndrome in mice.
Koblan LW; Erdos MR; Wilson C; Cabral WA; Levy JM; Xiong ZM; Tavarez UL; Davison LM; Gete YG; Mao X; Newby GA; Doherty SP; Narisu N; Sheng Q; Krilow C; Lin CY; Gordon LB; Cao K; Collins FS; Brown JD; Liu DR
Nature; 2021 Jan; 589(7843):608-614. PubMed ID: 33408413
[TBL] [Abstract][Full Text] [Related]
5. Impaired LEF1 Activation Accelerates iPSC-Derived Keratinocytes Differentiation in Hutchinson-Gilford Progeria Syndrome.
Mao X; Xiong ZM; Xue H; Brown MA; Gete YG; Yu R; Sun L; Cao K
Int J Mol Sci; 2022 May; 23(10):. PubMed ID: 35628310
[TBL] [Abstract][Full Text] [Related]
6. Telomerase therapy reverses vascular senescence and extends lifespan in progeria mice.
Mojiri A; Walther BK; Jiang C; Matrone G; Holgate R; Xu Q; Morales E; Wang G; Gu J; Wang R; Cooke JP
Eur Heart J; 2021 Nov; 42(42):4352-4369. PubMed ID: 34389865
[TBL] [Abstract][Full Text] [Related]
7. Cellular stress and AMPK activation as a common mechanism of action linking the effects of metformin and diverse compounds that alleviate accelerated aging defects in Hutchinson-Gilford progeria syndrome.
Finley J
Med Hypotheses; 2018 Sep; 118():151-162. PubMed ID: 30037605
[TBL] [Abstract][Full Text] [Related]
8. iPSC-Derived Endothelial Cells Affect Vascular Function in a Tissue-Engineered Blood Vessel Model of Hutchinson-Gilford Progeria Syndrome.
Atchison L; Abutaleb NO; Snyder-Mounts E; Gete Y; Ladha A; Ribar T; Cao K; Truskey GA
Stem Cell Reports; 2020 Feb; 14(2):325-337. PubMed ID: 32032552
[TBL] [Abstract][Full Text] [Related]
9. Recapitulation of premature ageing with iPSCs from Hutchinson-Gilford progeria syndrome.
Liu GH; Barkho BZ; Ruiz S; Diep D; Qu J; Yang SL; Panopoulos AD; Suzuki K; Kurian L; Walsh C; Thompson J; Boue S; Fung HL; Sancho-Martinez I; Zhang K; Yates J; Izpisua Belmonte JC
Nature; 2011 Apr; 472(7342):221-5. PubMed ID: 21346760
[TBL] [Abstract][Full Text] [Related]
10. A Tissue Engineered Blood Vessel Model of Hutchinson-Gilford Progeria Syndrome Using Human iPSC-derived Smooth Muscle Cells.
Atchison L; Zhang H; Cao K; Truskey GA
Sci Rep; 2017 Aug; 7(1):8168. PubMed ID: 28811655
[TBL] [Abstract][Full Text] [Related]
11. Expression of the Hutchinson-Gilford Progeria Mutation Leads to Aberrant Dentin Formation.
Choi H; Kim TH; Jeong JK; Strandgren C; Eriksson M; Cho ES
Sci Rep; 2018 Oct; 8(1):15368. PubMed ID: 30337599
[TBL] [Abstract][Full Text] [Related]
12. Hutchinson-Gilford progeria syndrome as a model for vascular aging.
Brassard JA; Fekete N; Garnier A; Hoesli CA
Biogerontology; 2016 Feb; 17(1):129-45. PubMed ID: 26330290
[TBL] [Abstract][Full Text] [Related]
13. Hutchinson-Gilford progeria patient-derived cardiomyocyte model of carrying LMNA gene variant c.1824 C > T.
Perales S; Sigamani V; Rajasingh S; Czirok A; Rajasingh J
Cell Tissue Res; 2023 Oct; 394(1):189-207. PubMed ID: 37572165
[TBL] [Abstract][Full Text] [Related]
14. Hutchinson-Gilford Progeria Syndrome (Hgps) and Application of Gene Therapy Based Crispr/Cas Technology as A Promising Innovative Treatment Approach.
Rajeev M; Ratan C; Krishnan K; Vijayan M
Recent Pat Biotechnol; 2021; 15(4):266-285. PubMed ID: 34602042
[TBL] [Abstract][Full Text] [Related]
15. The Molecular and Cellular Basis of Hutchinson-Gilford Progeria Syndrome and Potential Treatments.
Batista NJ; Desai SG; Perez AM; Finkelstein A; Radigan R; Singh M; Landman A; Drittel B; Abramov D; Ahsan M; Cornwell S; Zhang D
Genes (Basel); 2023 Feb; 14(3):. PubMed ID: 36980874
[TBL] [Abstract][Full Text] [Related]
16. Progerin Expression Induces Inflammation, Oxidative Stress and Senescence in Human Coronary Endothelial Cells.
Bidault G; Garcia M; Capeau J; Morichon R; Vigouroux C; Béréziat V
Cells; 2020 May; 9(5):. PubMed ID: 32408587
[TBL] [Abstract][Full Text] [Related]
17. Reprogramming progeria fibroblasts re-establishes a normal epigenetic landscape.
Chen Z; Chang WY; Etheridge A; Strickfaden H; Jin Z; Palidwor G; Cho JH; Wang K; Kwon SY; Doré C; Raymond A; Hotta A; Ellis J; Kandel RA; Dilworth FJ; Perkins TJ; Hendzel MJ; Galas DJ; Stanford WL
Aging Cell; 2017 Aug; 16(4):870-887. PubMed ID: 28597562
[TBL] [Abstract][Full Text] [Related]
18. Emerging candidate treatment strategies for Hutchinson-Gilford progeria syndrome.
Strandgren C; Revêchon G; Sola-Carvajal A; Eriksson M
Biochem Soc Trans; 2017 Dec; 45(6):1279-1293. PubMed ID: 29127216
[TBL] [Abstract][Full Text] [Related]
19. An overview of treatment strategies for Hutchinson-Gilford Progeria syndrome.
Harhouri K; Frankel D; Bartoli C; Roll P; De Sandre-Giovannoli A; Lévy N
Nucleus; 2018 Jan; 9(1):246-257. PubMed ID: 29619863
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
